To review the role of Na, K-ATPase inhibitors in the pathogenesis of essential hypertension and hypertension associated with end-stage renal disease.
Data Sources
MEDLINE search, 1966 to 1997.
Results
There is a suggestive physiologic and epidemiologic relationship between Na, K-ATPase inhibition and hypertension. However, clearance data cannot support the hypothesis that differential metabolism of this family of compounds explains the improved hypertensive control seen in patients on peritoneal dialysis compared to those on hemodialysis.
Conclusions
As a result of the complex methodologies involved, it is unclear whether Na, K-ATPase inhibitors playa significant role in the hypertension of endstage renal disease in general and peritoneal dialysis in particular.
SmithH.W.The kidney. Structure and function in health and disease.New York: Oxford University Press, 1951.
2.
BorstJ.G.G., Borst-DeGeusA.Hypertension explained by Starling's theory of circulatory homeostasis.Lancet1963; i: 677–82.
3.
GuytonA.C., ColemanT.G., CowleyA.V.Jr., ScheelK.W., ManningR.D.Jr., NormanR.A.Jr.Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.Am J Med1972; 52: 584–94.
4.
TobianL., BinionJ.T.Tissue cations and water in arterial hypertension.Circulation1952; 5: 754–8.
5.
TobianL., CoffeeK., McCreaP., DahlL.K.A comparison of the antihypertensive potency of kidneys from one strain of rats susceptible to salt hypertension and kidneys from another strain resistant to it.J Clin Invest1966; 45: 1080.
6.
DahlL.K., HeineM., ThompsonK.Genetic influence of the kidneys on blood pressure: Evidence from chronic renal homografts in rats with opposite predispositions to hypertension.Circ Res1974; 34: 94–101.
7.
BianchiG., FoxU., DiFrancescoG.F., BardiU., RadiceM.The hypertensive role of the kidney in spontaneously hypertensive rats.Clin Sci Mol Med1973; 45: 135–9.
8.
IwaiJ., DahlL.K., KnudsenK.D.Genetic influence on the renin-angiotensin system.Circ Res1973; 32: 678–84.
9.
LaraghJ.H., LetcherR.L., PickeringT.G.Renin profiling for diagnosis and treatment of hypertension.JAMA1979; 241: 151–6.
10.
DeWardenerH.E., MacGregorG.A.Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension.Kidney Int1980; 18: 1–9.
11.
MidgleyJP, MathewA.G., GreenwoodC.M.T., LoganA.G.Effect of reduced dietary sodium on blood pressure.JAMA1996; 275: 1590–7.
12.
DahlL.K., KnudsenK.D., HeineM., LeitlG.Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats: evidence for a humoral factor.J Exp Med1967; 126: 687–99.
13.
DeWardenerH.E., MillsI.H., ClaphamW.G., HayterC.J.Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog.Clin Sci1961; 21: 249–58.
14.
GonickH.C., KramerH.J., PaulW., LuE.Circulating inhibitor of sodium-potassium activated adenosine triphosphatase after expansion of extracellular fluid volume in rats.Clin Sci Mol Med1977; 53: 329–34.
15.
DeWardenerH.E.Kidney, salt intake and Na-K-ATPase inhibitors in hypertension.Hypertension1991; 17: 830–5.
HamlynJ.M., BlausteinM.P., BovaS., DuCharmeD.W., HarrisD.W., MandelF.Identification and characterization of a ouabain-like compound from human plasma.Proc Natl Acad Sci USA1991; 88: 6259–63.
18.
BlausteinM.P., HamlynJ.M.Sodium transport inhibition, cell calcium and hypertension.Am J Med1984; Oct: 45–59.
19.
BlausteinM.P.Endogenous ouabain: role in the pathogenesis of hypertension.Kidney Int1996; 49: 1748–53.
20.
BrickerN.S.On the pathogenesis of the uremic state: an exposition of the “trade-off” hypothesis.N Engl J Med1972; 286: 1093–9.
21.
AlejandroV.S.J., NelsonW.J., HuieP., SibleyR.K., DafoeD., KuoP.Postischemic injury, delayed function and Na, K-ATPase distribution in the transplanted kidney.Kidney Int1995; 48: 1308–15.
22.
VasdevS., JohnsonE., LongerichL., PrabhakaranV.M., GaultM.H.Plasma endogenous digitalis-like factors in healthy individuals and in dialysis dependent and kidney transplant patients.Clin Nephrol1987; 27: 169–74.
23.
KellyR.A., O'HaraD.S., MitchW.E., SteinmanT.I., GoldszerR.C., SolomonH.S.Endogenous digitalis-like factors in hypertension and chronic renal insufficiency.Kidney Int1986; 30: 723–9.
24.
VingeE., ErfurthE-M, Odar-CederlofI.Immunoreactive endogenous digoxin-like substances: Plasma levels are dependent on the hypothalamic-pituitaryadrenal axis for release and on kidney function for elimination.J Cardiovasc Pharmacol1993; 22(Suppl 2): Sl12–13.
BrearlyC.J., AronsonJ.K., BoonN.A., RaineA.E.G.Effects of haemodialysis and continuous ambulatory peritoneal dialysis on abnormalities of ion transport in vivo in patients with chronic renal failure.Clin Sci1993; 85: 725–31.
27.
YoungM.A., NolphK.D., DuttonS., ProwantB.Anti-hypertensive drug requirements in continuous ambulatory peritoneal dialysis.Perit Dial Bull1984; 4: 85–8.
WeilerE.W.J., SaldanhaL.F., Khalil-ManeshF., PrinsB.A., PurdyR.E., GonickH.C.Relationship of Na-KATPase inhibitors to blood pressure regulation in continuous ambulatory peritoneal dialysis and hemodialysis.J Am Soc Nephrol1996; 7: 454–63.
